Skip to main content
Premium Trial:

Request an Annual Quote

Linden to Provide Oligo Probe Design Service to PamGene

NEW YORK, Sept. 8 (GenomeWeb News) - Linden Bioscience has signed a deal to provide its Tilia oligonucloetide probe design service to Dutch biotech firm PamGene International, the companies said today.

PamGene plans to use the probes with its 5D-Pulse microarray platform, which is the basis for the company's FD10 system and soon-to-be launched PamStation 96 microarray system.

Specific terms of the arrangement were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.